AI-generated summary
In this retrospective study of 94 patients with burning mouth syndrome, the authors report that low-level laser therapy at 635 nm was followed by an immediate pain decrease in 71.3% of patients, with a mean visual analogue scale reduction of 2.2 points. The authors note no side effects were observed or reported, and that the study was retrospective.
- Participants
- 94
- Who or what was studied
- Patients with burning mouth syndrome treated with an intraoral semiconductor laser
- Wavelengths
- 635 nm
- Limits stated in the abstract
- The study is retrospective, and the abstract provides no control group, so the immediate pain changes cannot be attributed to the laser alone.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Significance
Burning mouth syndrome (BMS) is a chronic orofacial pain disorder that seriously affects quality of life of patients. In recent years, Low-level laser therapy (LLLT) has been regarded as an important innovation in pain management, but there is insufficient evidence of its effectiveness in patients with painful BMS. This study aimed to evaluate the efficacy of LLLT for immediate pain relief due to BMS.
Methods
This retrospective study included 94 BMS patients that were treated with an intraoral semiconductor laser (635 nm, 100 mW/cm2). Pain was self-assessed before and immediately after LLLT sessions using a 0-to-10 visual analogue scale (VAS). Paired-samples t-test and multivariable binary logistic regression were used to analyze overall efficacy and its influencing factors.
Results
After standardized LLLT session, 71.3% of patients reported an immediate pain decrease. Compared to pre-LLLT treatment, the VAS immediately post-LLLT was significantly reduced (P < 0.001). Mean post-LLLT VAS reduction was 2.2 ± 2.0, equivalent to 39.9% of the initial pain level. Meanwhile, low VAS before treatment, history of smoking or alcohol, xerostomia, and gingival lesions correlated with worse LLLT efficacy. There were no side effects or adverse reactions were noticed by the practitioner or reported by the patients.
Conclusions
LLLT may provide non-pharmacological, non-invasive, side-effect-free, and rapid pain relief for painful BMS patients. No baseline characteristics affecting overall efficiency were found except for VAS before treatment, history of smoking or alcohol, xerostomia, and gingival lesions.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 635 nm
- Power density (irradiance)
- 100 mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Visual analogue scale, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.